Back
The Chemours Vs. Moderna Industry Stock Comparison
Sell
27
CC
The Chemours
Last Price:
$19.90
Seasonality Move:
11.09%
Sell
14
MRNA
Moderna
Last Price:
$35.89
Seasonality Move:
19.97%
Sell
27
The Chemours (CC)
is a Sell
Is The Chemours a Buy, Sell or Hold?
-
The current The Chemours [CC] share price is $19.91. The Score for CC is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
CC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CC Stock Price Chart
What is The Chemours's stock price today?
-
The The Chemours share price today is $19.91Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CC is experiencing slight buying pressure.
CC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 62.69 | Buy |
Chaikin Money Flow: | 558028 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.06 - 18.94) | Buy |
Bollinger Bands (100): | (17.77 - 20.47) | Buy |
MRNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.08 | Sell |
Relative Strength Index (14 RSI): | 40.41 | Sell |
Chaikin Money Flow: | -6832643 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.4 - 43.1) | Sell |
Bollinger Bands (100): | (39.32 - 65.96) | Sell |
CC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.72 | Buy |
20-day SMA: | 17.86 | Buy |
50-day SMA: | 19.26 | Buy |
200-day SMA: | 21.73 | Sell |
8-day EMA: | 18.88 | Buy |
20-day EMA: | 18.5 | Buy |
50-day EMA: | 18.87 | Buy |
200-day EMA: | 21.5 | Sell |
MRNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.69 | Sell |
20-day SMA: | 39.41 | Sell |
50-day SMA: | 41.18 | Sell |
200-day SMA: | 85.56 | Sell |
8-day EMA: | 36.52 | Sell |
20-day EMA: | 38.81 | Sell |
50-day EMA: | 43.6 | Sell |
200-day EMA: | 72.35 | Sell |
The Chemours Earnings Growth & CC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $0.76 per share.
Moderna Earnings Growth & MRNA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $2.09 per share.
The Chemours Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Moderna Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |